Themes US R&D Champions ETFUSRDETF
13F holders, Q4 2024 (December 31)2holders +1
1new positions
0sold out
$29.73avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Themes US R&D Champions ETF (USRD) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Geneos Wealth Management Inc. ($19K) and UBS Group AG ($981).
- Company
- Themes US R&D Champions ETF
- CUSIP
- 882927874
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 680 shares bought, net +680 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Geneos Wealth Management Inc. | 0.00% | New | 650 | $19K |
| UBS Group AG | 0.00% | Add +1000.0% | 33 | $981 |
"% of holder's portfolio" is USRD's weight in each manager's 13F, not the share of Themes US R&D Champions ETF the manager owns.